Search Results
-
Targeting enzyme that fuels cancer cells
Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.
-
Joseph Wu to be AHA president
Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health.
-
Immunosuppression-free kidney transplant
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.
-
‘Anti-hunger’ molecule discovered
Stanford Medicine researchers and their collaborators have identified a molecule that staves off hunger post-exercise.
-
COVID-19 brain fog similar to chemo brain
Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.
-
Ketogenic diet helps cells survive stress
Muscle stem cells enter a deep resting state during fasting or when fed a high-fat ketogenic diet, a Stanford-led study finds. This promotes stem cell resilience but slows injury repair.
-
Brain plasticity leads to worse seizures
A brain mechanism needed for learning explains why epileptic seizures become more frequent, but a finding in rodents offers hope for treatment, according to a new study.
-
Electric current aids stroke recovery
Stanford scientists have developed a device that delivers and electrically stimulates stem cells to promote stroke healing.
-
Immunologist Samuel Strober dies at 81
Strober, a professor and former chief of immunology and rheumatology, found a way for transplant recipients to reduce or abandon immunosuppressive drugs yet avoid organ rejection.
-
Key molecule’s structure found at last
The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.